Cargando…
Transcription Factor Immunohistochemistry in the Diagnosis of Pituitary Tumors
Objective: The clinical utility and prognostic value of WHO 2017 lineage-based classification of pituitary tumors have not been assessed. This study aimed to (1) To determine the clinical utility of transcription factor analysis for classification of pituitary tumors and (2) To determine the prognos...
Autores principales: | Lenders, Nele F, Wilkinson, Adam C, Wong, Stephen J, Shein, Tint T, Harvey, Richard J, Inder, Warrick J, Earls, Peter E, McCormack, Ann I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090561/ http://dx.doi.org/10.1210/jendso/bvab048.1327 |
Ejemplares similares
-
The evolution in pituitary tumour classification: a clinical perspective
por: Lenders, Nele F, et al.
Publicado: (2023) -
Development of a cost-effective diagnostic algorithm incorporating transcription factor immunohistochemistry in the evaluation of pituitary tumours
por: Lenders, N. F., et al.
Publicado: (2022) -
PMON61 Evaluation of elevated IGF-1 in patients without clinical evidence of acromegaly
por: Careless, Laura, et al.
Publicado: (2022) -
SAT-288 Pituitary Developmental Defects Caused by Haploinsufficiency for the Transcription Factor SIX3 Are Worsened by POU1F1 Deficiency
por: Brinkmeier, Michelle, et al.
Publicado: (2020) -
New Transcriptional Insights into Silent and Active Corticotroph Pituitary Tumors at Single Cell Resolution
por: Zhang, Dongyun, et al.
Publicado: (2021)